glp-1 news 2025 october 16 Who Gets the Shot? Access by State The Multi-Sector Impacts of GLP-1RA

GLP-1 receptor agonists in either form share the class boxed warning for thyroid C-cell tumor risk observed in rodent studies

A key factor in affordability is income distribution

Watch the full interview to hear more: This is exactly what the market needsespecially as more employers are pulling back coverage of GLP-1s

If tolerated well and improvements continue, they may maintain or cautiously increase to 300400 mcg every other day or daily depending on individual response

Regulatory guidance now states: GLP-1 medicines may reduce the effectiveness of oral contraceptives Patients on Mounjaro (tirzepatide) HCP should not rely on oral contraception alone Additional or non-oral contraception is advised, especially during initiation and dose escalation Why

Usually, this goes away on its own